CTLA4 and melanoma: The RNA-seq data for Melanoma treated with anti-CTLA-4 therapy shows that the expression level of GSDMD significantly decreased after treatment (24) (log2FC = -1.1007), with a p-value of 0.021 (Supplementary Figure 4).